comparemela.com

Latest Breaking News On - International journal of industrial organization - Page 3 : comparemela.com

Antitrust markets in the pharmaceutical industry | VOX, CEPR Policy Portal

Eric Sun, Anupam Jena, Tomas Philipson , Darius Lakdawalla, Carolina Reyes, Dana Goldman Keeping medicine accessible at a reasonable cost is a challenge.  An important component of public authorities’ strategies has been to stimulate price competition from generics. Yet a perplexing feature surrounding generic entry is that the price of the other on-patent potential substitutes is barely affected (Jena et al. 2009, Lakdawalla 2018), and their volume market share even tends to increase (Grabowski et al. 2014, Lakdawalla and Philipson 2012, Castanheira et al. 2019).  The absence of a price reaction on the part of drugs still benefitting from exclusivity has sometimes led competition authorities to conclude that a single molecule (and not the set of drugs that are used to treat the same condition) may constitute a distinct antitrust market.  These findings stirred some controversy.

Andrea Coscelli: Ahead of the curve - Bannerman Competition Lecture

9 February 2021 (Original script, may differ from delivered version) It is an honour to be joining you all, virtually, to give the Bannerman Competition Lecture. In his time, Ron Bannerman was a pioneer and a forward-thinker. It seems self-evident now that the business cartels he confronted caused harm to Australian consumers and the economy. But his work over 2 decades to cut back at what he later described as the ‘astonishing web of restrictions’ [footnote 1] across Australian industry was conducted in the face of considerable resistance and antagonism. His commitment and persistence were crucial to the development of the strong culture of fair and open competition that now prevails in Australia.

Andrea Coscelli Ahead of curve - Bannerman Competition Lecture

Date Time Andrea Coscelli Ahead of curve – Bannerman Competition Lecture It is an honour to be joining you all, virtually, to give the Bannerman Competition Lecture. In his time, Ron Bannerman was a pioneer and a forward-thinker. It seems self-evident now that the business cartels he confronted caused harm to Australian consumers and the economy. But his work over 2 decades to cut back at what he later described as the ‘astonishing web of restrictions’ [footnote 1] across Australian industry was conducted in the face of considerable resistance and antagonism. His commitment and persistence were crucial to the development of the strong culture of fair and open competition that now prevails in Australia.

Travelers From Italy May Have Driven First US COVID-19 Wave More Than Those From China

The coronavirus was still a far-away problem in Wuhan when U.S. President Donald Trump announced a ban on travel from China in late January 2020. Six weeks later, as the coronavirus ravaged Italy, Trump closed travel from Europe. These travel bans were highly controversial. Some people argued that they were unnecessary restrictions on travel. Others said they came too late. As New York’s COVID-19 case numbers shot upward, Gov. Andrew Cuomo said the U.S. had “closed the front door with the China ban … but we left the back door wide open,” because the virus had already spread to other countries.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.